Literature DB >> 442166

The problem of emesis during oral glucose-electrolytes therapy given from the onset of severe cholera.

D R Nalin, M M Levine, R B Hornick, E J Bergquist, D Hoover, H P Holley, D Waterman, J VanBlerk, S Matheny, S Sotman, M Rennels.   

Abstract

In an attempt to obviate the need for intravenous fluids by preventing dehydration, 57 adult volunteers who experienced induced clinical cholera during a vaccine development programme were treated from the onset of diarrhoea with oral glucose-electrolytes therapy. 44 individuals with mild to moderately profuse diarrhoea (less than 8 L. total volume) were maintained in normal water and electrolyte balance with oral therapy alone. 13 individuals with severe diarrhoea (greater than 8 L. total volume) could not be maintained in balance with oral therapy alone, due chiefly to emesis during the first day of illness. Emesis occurred in the absence of significant dehydration or acidosis. Since emesis precludes effective early oral therapy in severe cases, domiciliary oral therapy is unlikely to eliminate cholera mortality. Rural diarrhoea treatment centres using oral therapy with limited amounts of intravenous fluids when needed, could reduce case fatality from cholera and related diarrhoeas virtually to zero with least expense.

Entities:  

Mesh:

Year:  1979        PMID: 442166     DOI: 10.1016/0035-9203(79)90120-2

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.

Authors:  M M Levine; J B Kaper; D Herrington; G Losonsky; J G Morris; M L Clements; R E Black; B Tall; R Hall
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

Review 2.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

3.  Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.

Authors:  C O Tacket; B Forrest; R Morona; S R Attridge; J LaBrooy; B D Tall; M Reymann; D Rowley; M M Levine
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine.

Authors:  M M Levine; R E Black; M L Clements; C Lanata; S Sears; T Honda; C R Young; R A Finkelstein
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

5.  Health care-seeking behavior during childhood diarrheal illness: results of health care utilization and attitudes surveys of caretakers in western Kenya, 2007-2010.

Authors:  Richard Omore; Ciara E O'Reilly; John Williamson; Fenny Moke; Vincent Were; Tamer H Farag; Anna Maria van Eijk; Karen L Kotloff; Myron M Levine; David Obor; Frank Odhiambo; John Vulule; Kayla F Laserson; Eric D Mintz; Robert F Breiman
Journal:  Am J Trop Med Hyg       Date:  2013-04-29       Impact factor: 2.345

6.  Massive fluid requirements and an unusual BUN/creatinine ratio for pre-renal failure in patients with cholera.

Authors:  Muhammad Tariq; Murtaza Memon; Asif Jafferani; Sana Shoukat; Saqib Ali Gowani; Rabeeya Nusrat; Mehmood Riaz; Junaid Patel; Bushra Jamil; Raymond A Smego
Journal:  PLoS One       Date:  2009-10-26       Impact factor: 3.240

Review 7.  Issues and Controversies in the Evolution of Oral Rehydration Therapy (ORT).

Authors:  David Nalin
Journal:  Trop Med Infect Dis       Date:  2021-03-12

Review 8.  The History of Intravenous and Oral Rehydration and Maintenance Therapy of Cholera and Non-Cholera Dehydrating Diarrheas: A Deconstruction of Translational Medicine: From Bench to Bedside?

Authors:  David R Nalin
Journal:  Trop Med Infect Dis       Date:  2022-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.